Federal contract award
75N93021P00275
ALANINE SCANNING MUTANT PLASMIDS FOR SARS COV2 SPIKE PROTEIN
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | Q301 — Reference Laboratory Testing |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $5.5K |
| Current contract value | $5.5K |
| Potential contract value / ceiling | $5.5K |
| Start date | Jan 25, 2021 |
| Current end date | Jan 25, 2022 |
| Potential end date | Jan 25, 2022 |
| Latest award activity | Aug 24, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 24, 2026 | P00001 | $-27.5K | TO ADMINISTRATE DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. |
| Jan 25, 2021 | 0 | $33.0K | ALANINE SCANNING MUTANT PLASMIDS FOR SARS COV2 SPIKE PROTEIN |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.